Open biopsy in patients with acute progressive neurologic decline and absence of mass lesion
- PMID: 20679635
- PMCID: PMC2918468
- DOI: 10.1212/WNL.0b013e3181eb5889
Open biopsy in patients with acute progressive neurologic decline and absence of mass lesion
Abstract
Objective: Patients with acute to subacute neurologic decline undergo a battery of imaging and laboratory tests to determine a diagnosis and treatment plan. Often, after an extensive evaluation, a brain biopsy is recommended as yet another tool to assist in determining the diagnosis. The goal of this retrospective cohort analysis is to measure the sensitivity of open brain biopsy in this patient population, compare these results with the preoperative presumed diagnosis, and evaluate if the biopsy result significantly alters treatment.
Methods: The authors reviewed the medical records of 135 consecutive patients who underwent open brain biopsies for acute to subacute progressive neurologic decline between January 1999 and September 2008 at a single institution. All patients with mass lesions, with HIV/AIDS, and who were younger than 20 years of age were excluded from the study. Fifty-one patients met these criteria and all preoperative tests, imaging, and treatment plans were examined and compared with postbiopsy interventions to determine the impact of the biopsy on patient outcome.
Results: The sensitivity of open brain biopsy at our institution was 35%. The most common preoperative presumed diagnosis was vasculitis and the most common postoperative finding was Creutzfeldt-Jakob disease, followed by amyloid angiopathy. Postbiopsy hemorrhage was a complication in 4% of patients. Treatment plans changed as a direct result of the biopsy in 8% of patients, and in only 4% did the biopsy findings make a difference in disease course.
Conclusion: In patients with progressive neurologic decline without a radiographic mass lesion or immunodeficiency, open brain biopsy often fails to provide a diagnosis and even more rarely does it significantly alter treatment.
Figures
Comment in
-
Open biopsy in patients with acute progressive neurologic decline and absence of mass lesion.Neurology. 2011 May 24;76(21):1847; author reply 1847-8. doi: 10.1212/WNL.0b013e318210e621. Neurology. 2011. PMID: 21606461 No abstract available.
Similar articles
-
Evaluation of brain biopsy in the diagnosis of severe neurologic disease of unknown etiology.Clin Neurol Neurosurg. 2009 Apr;111(3):235-9. doi: 10.1016/j.clineuro.2008.10.003. Epub 2008 Nov 20. Clin Neurol Neurosurg. 2009. PMID: 19022558 Clinical Trial.
-
Open biopsy in patients with acute progressive neurologic decline and absence of mass lesion.Neurology. 2011 May 24;76(21):1847; author reply 1847-8. doi: 10.1212/WNL.0b013e318210e621. Neurology. 2011. PMID: 21606461 No abstract available.
-
Comprehensive assessment of hemorrhage risks and outcomes after stereotactic brain biopsy.J Neurosurg. 2001 Apr;94(4):545-51. doi: 10.3171/jns.2001.94.4.0545. J Neurosurg. 2001. PMID: 11302651
-
Brain biopsy using high-field strength interventional magnetic resonance imaging.Neurosurgery. 1999 Apr;44(4):807-13; discussion 813-4. doi: 10.1097/00006123-199904000-00067. Neurosurgery. 1999. PMID: 10201306 Review.
-
Primary angiitis of the central nervous system: diagnostic criteria and clinical approach.Cleve Clin J Med. 1992 May-Jun;59(3):293-306. doi: 10.3949/ccjm.59.3.293. Cleve Clin J Med. 1992. PMID: 1516217 Review.
Cited by
-
Impact of brain biopsy on management of nonneoplastic brain disease.Brain Spine. 2022 Jan 19;2:100863. doi: 10.1016/j.bas.2022.100863. eCollection 2022. Brain Spine. 2022. PMID: 36248174 Free PMC article.
-
Clinical Laboratory Tests Used To Aid in Diagnosis of Human Prion Disease.J Clin Microbiol. 2019 Sep 24;57(10):e00769-19. doi: 10.1128/JCM.00769-19. Print 2019 Oct. J Clin Microbiol. 2019. PMID: 31366689 Free PMC article. Review.
-
Diagnostic Testing of Neurologic Infections.Neurol Clin. 2018 Nov;36(4):687-703. doi: 10.1016/j.ncl.2018.07.004. Neurol Clin. 2018. PMID: 30366549 Free PMC article. Review.
-
Brain biopsies requiring Creutzfeldt-Jakob disease precautions in the Republic of Ireland 2005-2016.Ir J Med Sci. 2018 May;187(2):515-520. doi: 10.1007/s11845-017-1673-1. Epub 2017 Aug 12. Ir J Med Sci. 2018. PMID: 28803271
-
Brain biopsy in neurologic decline of unknown etiology.Hum Pathol. 2015 Apr;46(4):499-506. doi: 10.1016/j.humpath.2014.12.003. Epub 2014 Dec 31. Hum Pathol. 2015. PMID: 25661242 Free PMC article.
References
-
- Josephson SA, Papanastassiou AM, Berger MS, et al. The diagnostic utility of brain biopsy procedures in patients with rapidly deteriorating neurological conditions or dementia. J Neurosurg 2007;106:72–75. - PubMed
-
- Warren JD, Schott JM, Fox NC, et al. Brain biopsy in dementia. Brain 2005;128:2016–2025. - PubMed
-
- Burns JD, Cadigan RO, Russell JA. Evaluation of brain biopsy in the diagnosis of severe neurologic disease of unknown etiology. Clin Neurol Neurosurg 2009;111:235–239. - PubMed
-
- Javedan SP, Tamargo RJ. Diagnostic yield of brain biopsy in neurodegenerative disorders. Neurosurgery 1997;41:823–828; discussion 8–30. - PubMed
-
- Kaufman HH, Catalano LW Jr. Diagnostic brain biopsy: a series of 50 cases and a review. Neurosurgery 1979;4:129–136. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous